Mounjaro (tirzepatide): Side effects can include GI symptoms, low blood sugar and decreased appetite, which can contribute to tiredness
For the OSA indication, separate criteria apply: Polysomnography documenting moderate-to-severe OSA (typically AHI 15+) BMI 30 or higher CPAP intolerance, insufficiency, or contraindication documentation Sleep medicine physician co-signature in some plans The December 2024 OSA pathway The FDA's December 2024 approval of tirzepatide (Zepbound) for moderate-to-severe obstructive sleep apnea in adults with obesity, based on the SURMOUNT-OSA trials (Malhotra et al., New England Journal of Medicine 2024), created a new coverage pathway
He has suffered repeated calf tears from soccer and multiple reinjuries caused by returning too quickly
HR teams set budgets and rules once, then manage programs with significantly less manual effort (regardless of whether they support 100 employees or 10,000)
In contrast, metformin reduces body weight by an average of 5% after six months